FindTrial
Sign In

clinical study to evaluate the efficacy of mukhadushikahar lepa and clindamycin in the management of mukhadushika with special reference to acne vulgaris

Randomised controlled clinical study to evaluate the efficacy of mukhadushikahar lepa and clindamycin in the management of mukhadushika with special reference to acne vulgaris - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098975
Enrollment
90
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Abhimanyu Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of either sex between the Age group of 13 30 years. Willingness to give informed consent. Voluntarily desires to take treatment.

Exclusion criteria

Exclusion criteria: Severe cases of acne vulgaris Known hypersensitivity to trial or control drug. Pregnant or lactating women. Systemic illness like Diabetes Mellitus and Thyroid Disease

Design outcomes

Primary

MeasureTime frame
To study the clinical efficacy of MukhdushikaharLepa in the management of Tarunyapidika (Acne Vulgaris). To compare the clinical efficacy of Mukhdushikahar Lepa and local application of Clindamycin in the management of Mukhadushika (AcnE Vulgaris). Timepoint: alternate 30 days (once a day)—

Secondary

MeasureTime frame
To assess the safety & tolerability of both interventions. To evaluate recurrence rate in post-treatment. Timepoint: alternate 30 days (once a day)—

Countries

India

Contacts

Public ContactDr Jyoti B Choure

LRPAMCH, ISLAMPUR

jyotichoure23@gmail.com9423471756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026